CYP17A1 and benign prostatic hyperplasia: The findings from our analysis reveal that genetic polymorphism in the ACE gene was significantly associated with the risk of BPH when compared with control subjects, whereas the polymorphism located in VDR and CYP17 genes failed to do so (Table 2, Fig. 2).